Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

  • Lorenzo-Sanz, Laura|||0000-0001-6477-2163
  • Lopez-Cerda, Marta|||0000-0002-6511-0302
  • da Silva-Diz, Victoria
  • Artés, Marta H.
  • Llop, Sandra
  • Penin, Rosa M.
  • Bermejo, Josep Oriol|||0000-0002-8581-9415
  • González-Suárez, Eva|||0000-0003-0858-8171
  • Esteller, M.|||0000-0003-4490-6093
  • Viñals, Francesc|||0000-0002-9918-6751
  • Espinosa, Enrique|||0000-0001-6562-7902
  • Oliva, Marc|||0000-0001-5352-8130
  • Piulats, Josep M.|||0000-0002-3606-1724
  • Martín Liberal, Juan
  • Muñoz, Purificación|||0000-0002-3751-2099
Immune checkpoint blockade (ICB) approaches have changed the therapeutic landscape for many tumor types. However, half of cutaneous squamous cell carcinoma (cSCC) patients remain unresponsive or develop resistance. Here, we show that, during cSCC progression in male mice, cancer cells acquire epithelial/mesenchymal plasticity and change their immune checkpoint (IC) ligand profile according to their features, dictating the IC pathways involved in immune evasion. Epithelial cancer cells, through the PD-1/PD-L1 pathway, and mesenchymal cancer cells, through the CTLA-4/CD80 and TIGIT/CD155 pathways, differentially block antitumor immune responses and determine the response to ICB therapies. Accordingly, the anti-PD-L1/TIGIT combination is the most effective strategy for blocking the growth of cSCCs that contain both epithelial and mesenchymal cancer cells. The expression of E-cadherin/Vimentin/CD80/CD155 proteins in cSCC, HNSCC and melanoma patient samples predicts response to anti-PD-1/PD-L1 therapy. Collectively, our findings indicate that the selection of ICB therapies should take into account the epithelial/mesenchymal features of cancer cells.
Dipòsit Digital de Documents de la UAB
Publicación Capítulo o parte de un libro (BookPart)

Peptidomics Methods Applied to the Study of Flower Development

  • Álvarez-Urdiola, Raquel|||0000-0001-8943-5147
  • Borràs, Eva|||0000-0002-3859-9907
  • Valverde, Federico
  • Matus, José Tomás|||0000-0002-9196-1813
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Riechmann, José Luis|||0000-0003-1108-1945
Understanding the global and dynamic nature of plant developmental processes requires not only the study of the transcriptome, but also of the proteome, including its largely uncharacterized peptidome fraction. Recent advances in proteomics and high-throughput analyses of translating RNAs (ribosome profiling) have begun to address this issue, evidencing the existence of novel, uncharacterized, and possibly functional peptides. To validate the accumulation in tissues of sORF-encoded polypeptides (SEPs), the basic setup of proteomic analyses (i.e., LC-MS/MS) can be followed. However, the detection of peptides that are small (up to ~100 aa, 6-7 kDa) and novel (i.e., not annotated in reference databases) presents specific challenges that need to be addressed both experimentally and with computational biology resources. Several methods have been developed in recent years to isolate and identify peptides from plant tissues. In this chapter, we outline two different peptide extraction protocols and the subsequent peptide identification by mass spectrometry using the database search or the de novo identification methods.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1

  • Simonet, Nicolas G.|||0000-0001-9921-7645
  • Thackray, Joshua K.|||0000-0003-2828-452X
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Ianni, Alessandro|||0000-0001-7398-589X
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Morales-Sanfrutos, J.
  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Buschbeck, Marcus|||0000-0002-3218-4567
  • Tischfield, J.
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Esteller, M.|||0000-0003-4490-6093
  • Braun, Thomas|||0000-0002-6165-4804
  • Olivella, Mireia|||0000-0002-6035-3399
  • Serrano, L.
  • Vaquero, Alejandro|||0000-0002-8735-4156
Sirtuins are key players of metabolic stress response. Originally described as deacetylases, some sirtuins also exhibit poorly understood mono-adenosine 5'-diphosphate (ADP)-ribosyltransferase (mADPRT) activity. We report that the deacetylase SirT7 is a dual sirtuin, as it also features auto-mADPRT activity. SirT7 mADPRT occurs at a previously undefined active site, and its abrogation alters SirT7 chromatin distribution. We identify an epigenetic pathway by which ADP-ribosyl-SirT7 is recognized by the ADP-ribose reader mH2A1.1 under glucose starvation, inducing SirT7 relocalization to intergenic regions. SirT7 promotes mH2A1 enrichment in a subset of nearby genes, many of them involved in second messenger signaling, resulting in their specific up- or down-regulation. The expression profile of these genes under calorie restriction is consistently abrogated in SirT7-deficient mice, resulting in impaired activation of autophagy. Our work provides a novel perspective on sirtuin duality and suggests a role for SirT7/mH2A1.1 axis in glucose homeostasis and aging.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey

  • Hüls, Anke|||0000-0002-6005-417X
  • Costa, Alberto C. S.
  • Dierssen, Mara|||0000-0003-0853-6865
  • Baksh, Asaad|||0000-0001-6596-2145
  • Bargagna, Stefania
  • Baumer, Nicole
  • Brandão, Ana Claudia
  • Carfi, Angelo|||0000-0002-9837-7003
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Chicoine, Brian|||0000-0002-1520-3893
  • Ghosh, Sujay
  • Lakhanpaul, Monica
  • Manso, Coral
  • Mayer, Miguel-Angel
  • Ortega, Maria del Carmen
  • de Asua, Diego Real
  • Rebillat, Anne-Sophie|||0000-0003-1995-9177
  • Russell, Lauren Ashley
  • Sgandurra, Giuseppina
  • Valentini, Diletta
  • Sherman, Stephanie L.
  • Strydom, Andre
Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. The T21RS COVID-19 Initiative launched an international survey for clinicians or caregivers on patients with COVID-19 and DS. Data collected between April and October 2020 (N=1046) were analysed and compared with the UK ISARIC4C survey of hospitalized COVID-19 patients with and without DS. The mean age of COVID-19 patients with DS in the T21RS survey was 29 years (SD = 18). Similar to the general population, the most frequent signs and symptoms of COVID-19 were fever, cough, and shortness of breath. Joint/muscle pain and vomiting or nausea were less frequent (p < 0.01), whereas altered consciousness/confusion were more frequent (p < 0.01). Risk factors for hospitalization and mortality were similar to the general population with the addition of congenital heart defects as a risk factor for hospitalization. Mortality rates showed a rapid increase from age 40 and were higher in patients with DS (T21RS DS versus non-DS patients: risk ratio (RR) = 3.5 (95%-CI=2.6;4.4), ISARIC4C DS versus non-DS patients: RR = 2.9 (95%-CI=2.1;3.8)) even after adjusting for known risk factors for COVID-19 mortality. Leading signs/symptoms of COVID-19 and risk factors for severe disease course are similar to the general population. However, individuals with DS present significantly higher rates of medical complications and mortality, especially from age 40. Down Syndrome Affiliates in Action, DSMIG-USA, GiGi's Playhouse, Jerome Lejeune Foundation, LuMind IDSC Foundation, The Matthew Foundation, NDSS, National Task Group on Intellectual Disabilities and Dementia Practices.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction

  • Domingo-Rodriguez, Laura|||0000-0003-3286-6696
  • Ruiz de Azua, Inigo
  • Dominguez, Eduardo
  • Senabre, Eric|||0000-0001-8507-8154
  • Serra, Irene
  • Kummer, Sami
  • Navandar, Mohit
  • Baddenhausen, Sarah|||0000-0001-9847-6960
  • Hofmann, Clementine
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Gerber, Susanne
  • Navarrete, Marta|||0000-0003-2097-4788
  • Dierssen, Mara|||0000-0003-0853-6865
  • Lutz, Beat|||0000-0002-1062-6889
  • Martín-García, Elena|||0000-0002-4487-3028
  • Maldonado, Rafael|||0000-0002-4359-8773
Food addiction is linked to obesity and eating disorders and is characterized by a loss of behavioral control and compulsive food intake. Here, using a food addiction mouse model, we report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic neurons prevents the development of food addiction-like behavior, which is associated with enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological mechanism underlying resilience and vulnerability to the development of food addiction, which could pave the way towards novel and efficient interventions for this disorder. Food addiction is linked to obesity and eating disorders. In a mouse model of food addiction, the authors show that a medial prefrontal cortex-nucleus accumbens pathway is involved in vulnerability and resilience against the development of food addiction-like behavior.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients, A Mini-Review

  • Bradbury, Melissa|||0000-0003-4974-8899
  • Borràs, Eva|||0000-0002-3859-9907
  • Pérez-Benavente, Assumpció|||0000-0003-1872-9003
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Santamaría Margalef, Anna|||0000-0001-6726-8990
  • Sabidó, Eduard|||0000-0001-6506-7714
In this manuscript, we review the management strategies available for high-grade serous ovarian cancer patients and the molecular advances that are helping improve our understanding of the tumor and its response to treatment. We emphasize the role that proteomics is now playing in the study of ovarian cancer tumors and how its integration with genomics can guide the development of new biomarkers and therapeutic targets. High-grade serous ovarian cancer (HGSC) remains the most common and deadly subtype of ovarian cancer. It is characterized by its late diagnosis and frequent relapse despite standardized treatment with cytoreductive surgery and platinum-based chemotherapy. The past decade has seen significant advances in the clinical management and molecular understanding of HGSC following the publication of the Cancer Genome Atlas (TCGA) researchers and the introduction of targeted therapies with anti-angiogenic drugs and poly(ADP-ribose) polymerase inhibitors in specific subgroups of patients. We provide a comprehensive review of HGSC, focusing on the most important molecular advances aimed at providing a better understanding of the disease and its response to treatment. We emphasize the role that proteomic technologies are now playing in these two aspects of the disease, through the identification of proteins and their post-translational modifications in ovarian cancer tumors. Finally, we highlight how the integration of proteomics with genomics, exemplified by the work performed by the Clinical Proteomic Tumor Analysis Consortium (CPTAC), can guide the development of new biomarkers and therapeutic targets.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling

  • Bradbury, Melissa|||0000-0003-4974-8899
  • Castellvi, Josep|||0000-0001-5745-9996
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Sánchez Iglesias, José Luis|||0000-0002-4542-3969
  • Pérez-Benavente, Assumpció|||0000-0003-1872-9003
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Santamaría Margalef, Anna|||0000-0001-6726-8990
  • Borràs, Eva|||0000-0002-3859-9907
Despite recent advances in the management of BRCA1 mutated high-grade serous ovarian cancer (HGSC), the physiology of these tumors remains poorly understood. Here we provide a comprehensive molecular understanding of the signaling processes that drive HGSC pathogenesis with the addition of valuable ubiquitination profiling, and their dependency on BRCA1 mutation-state directly in patient-derived tissues. Using a multilayered proteomic approach, we show the tight coordination between the ubiquitination and phosphorylation regulatory layers and their role in key cellular processes related to BRCA1-dependent HGSC pathogenesis. In addition, we identify key bridging proteins, kinase activity, and post-translational modifications responsible for molding distinct cancer phenotypes, thus providing new opportunities for therapeutic intervention, and ultimately advance towards a more personalized patient care.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptome innovations in primates revealed by single-molecule long-read sequencing

  • Ferrández-Peral, Luis|||0000-0003-0338-0603
  • Zhan, Xiaoyu
  • Alvarez-Estape, Marina|||0000-0001-8242-1092
  • Chiva, Cristina
  • Esteller-Cucala, Paula|||0000-0003-3048-4280
  • García Perez, Raquel|||0000-0002-2573-6984
  • Julià, Eva|||0000-0002-9722-4662
  • Lizano, Esther|||0000-0003-3304-9807
  • Fornas, Òscar|||0000-0003-2017-9100
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Li, Qiye
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Juan, David|||0000-0003-1912-9667
  • Zhang, Guojie|||0000-0001-6860-1521
Transcriptomic diversity greatly contributes to the fundamentals of disease, lineage-specific biology, and environmental adaptation. However, much of the actual isoform repertoire contributing to shaping primate evolution remains unknown. Here, we combined deep long- and short-read sequencing complemented with mass spectrometry proteomics in a panel of lymphoblastoid cell lines (LCLs) from human, three other great apes, and rhesus macaque, producing the largest full-length isoform catalog in primates to date. Around half of the captured isoforms are not annotated in their reference genomes, significantly expanding the gene models in primates. Furthermore, our comparative analyses unveil hundreds of transcriptomic innovations and isoform usage changes related to immune function and immunological disorders. The confluence of these evolutionary innovations with signals of positive selection and their limited impact in the proteome points to changes in alternative splicing in genes involved in immune response as an important target of recent regulatory divergence in primates.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short- and medium-term air pollution exposure, plasmatic protein levels and blood pressure in children

  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Warembourg, Charline|||0000-0003-2716-9167
  • Dedele, Audrius
  • Heude, Barbara
  • Borràs, Eva|||0000-0002-3859-9907
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Aasvang, Gunn Marit
  • Lepeule, Johanna|||0000-0001-8907-197X
  • Wright, John|||0000-0001-9572-7293
  • Urquiza, Jose|||0000-0003-2220-607X
  • Gützkow, Kristine B.
  • Maitre, Léa|||0000-0003-3682-7117
  • Chatzi, Leda
  • Casas, Maribel
  • Vafeiadi, Marina
  • Nieuwenhuijsen, Mark|||0000-0001-9461-7981
  • de Castro, Montserrat
  • Grazuleviciene, Regina|||0000-0002-0210-8053
  • McEachan, Rosemary R.C.
  • Basagaña, X.|||0000-0002-8457-1489
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Sunyer, Jordi
  • Bustamante, Mariona|||0000-0003-0127-2860
Exposure to air pollution influences children's health, however, the biological mechanisms underlying these effects are not completely elucidated. We investigated the association between short- and medium-term outdoor air pollution exposure with protein profiles and their link with blood pressure in 1170 HELIX children aged 6-11 years. Different air pollutants (NO2, PM10, PM2.5, and PM2.5abs) were estimated based on residential and school addresses at three different windows of exposure (1-day, 1-week, and 1-year before clinical and molecular assessment). Thirty-six proteins, including adipokines, cytokines, or apolipoproteins, were measured in children's plasma using Luminex. Systolic and diastolic blood pressure (SBP and DBP) were measured following a standardized protocol. We performed an association study for each air pollutant at each location and time window and each outcome, adjusting for potential confounders. After correcting for multiple-testing, hepatocyte growth factor (HGF) and interleukin 8 (IL8) levels were positively associated with 1-week home exposure to some of the pollutants (NO2, PM10, or PM2.5). NO2 1-week home exposure was also related to higher SBP. The mediation study suggested that HGF could explain 19% of the short-term effect of NO2 on blood pressure, but other study designs are needed to prove the causal directionality between HGF and blood pressure.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations of four biological age markers with child development, A multi-omic analysis in the European HELIX cohort

  • Robinson, Oliver|||0000-0002-4735-0468
  • Lau, Chungho E.
  • Joo, Sungyeon
  • Andrusaityte, Sandra|||0000-0002-4309-0208
  • Borràs, Eva|||0000-0002-3859-9907
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Chatzi, Lida|||0000-0002-3319-2438
  • Keun, Hector C.
  • Grazuleviciene, Regina|||0000-0002-0210-8053
  • Gutzkow, Kristine B.|||0000-0002-6716-5921
  • Maitre, Lea
  • Martens, Dries S.
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Siroux, Valérie
  • Urquiza, Jose|||0000-0003-2220-607X
  • Vafeiadi, Marina
  • Wright, John|||0000-0001-9572-7293
  • Nawrot, Tim S.|||0000-0002-3583-3593
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Vrijheid, Martine|||0000-0002-7090-1758
Background: While biological age in adults is often understood as representing general health and resilience, the conceptual interpretation of accelerated biological age in children and its relationship to development remains unclear. We aimed to clarify the relationship of accelerated biological age, assessed through two established biological age indicators, telomere length and DNA methylation age, and two novel candidate biological age indicators, to child developmental outcomes, including growth and adiposity, cognition, behavior, lung function and the onset of puberty, among European school-age children participating in the HELIX exposome cohort. Methods: The study population included up to 1173 children, aged between 5 and 12 years, from study centres in the UK, France, Spain, Norway, Lithuania, and Greece. Telomere length was measured through qPCR, blood DNA methylation, and gene expression was measured using microarray, and proteins and metabolites were measured by a range of targeted assays. DNA meth-ylation age was assessed using Horvath's skin and blood clock, while novel blood transcriptome and 'immunometabolic' (based on plasma proteins and urinary and serum metabolites) clocks were derived and tested in a subset of children assessed six months after the main follow-up visit. Associations between biological age indicators with child developmental measures as well as health risk factors were estimated using linear regression, adjusted for chronological age, sex, ethnicity, and study centre. The clock derived markers were expressed as Δ age (i.e. predicted minus chronological age). Results: Transcriptome and immunometabolic clocks predicted chronological age well in the test set (r=0.93 and r=0.84 respectively). Generally, weak correlations were observed, after adjustment for chronological age, between the biological age indicators. Among associations with health risk factors, higher birthweight was associated with greater immunometabolic Δ age, smoke exposure with greater DNA methylation Δ age, and high family affluence with longer telomere length. Among associations with child developmental measures, all biological age markers were associated with greater BMI and fat mass, and all markers except telomere length were associated with greater height, at least at nominal significance (p<0.05). Immunometabolic Δ age was associated with better working memory (p=4 e-3) and reduced inattentiveness (p=4 e-4), while DNA methylation Δ age was associated with greater inattentiveness (p=0.03) and poorer externalizing behaviors (p=0.01). Shorter telomere length was also associated with poorer externalizing behaviors (p=0.03). Conclusions: In children, as in adults, biological aging appears to be a multi-faceted process and adiposity is an important correlate of accelerated biological aging. Patterns of associations suggested that accelerated immunometabolic age may be beneficial for some aspects of child development while accelerated DNA methylation age and telomere attrition may reflect early detri-mental aspects of biological aging, apparent even in children.